Evidence map›Paper›PMID 41388596›Full record

ArticleBiotechnology and bioengineering2026

Over-Expression of a Phycocyanin-Interferon Fusion and Differential Cleaving Efficiency in Cyanobacteria (Synechocystis sp. PCC 6803).

Bharat Kumar Majhi, Anastasios Melis

Abstract read
In one paragraph

Article in Biotechnology and bioengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bharat Kumar MajhiDepartment of Plant and Microbial Biology, University of California, Berkeley, California, USA.ORCID 0009-0001-2709-1446
Anastasios MelisDepartment of Plant and Microbial Biology, University of California, Berkeley, California, USA.

Funding

UC Berkeley Fund 63742.
6 · The paper itself

Abstract

Recombinant protein expression in heterologous biological systems is an expanding field in synthetic biology. Photosynthetic organisms have the potential to provide an efficient low-cost platform for recombinant protein production because they require minimal growth nutrients and are less susceptible to zoonotic and other contaminants. Cyanobacteria are a class of microorganisms that are gaining as the preferred photosynthetic cell factories for product generation. In this study, the cyanobacterium Synechocystis sp. PCC 6803 was used as a host to stably over-express a functional form of the human interferon α-2 (IFN), as a fusion construct with the abundant CpcB β-subunit of phycocyanin. To cleave and isolate the free form of IFN from the fusion protein, different constructs were designed containing the Tobacco Etch Virus (TEV) or Human Rhinovirus (hrv) 3 C protease cleaving loci, placed between the leading CpcB and trailing IFN moieties of the fusion proteins. The work examined the comparative cleaving efficacy of TEV and HRV proteases in separating IFN from such over-expressed phycocyanin fusion protein complexes. It was concluded that the HRV protease system is superior to that of TEV, and that of other cleaving proteases recently tested, and may thus be incorporated in the toolkit of cyanobacterial synthetic biology for recombinant protein synthesis and isolation.

Indexed as

PhycocyaninRecombinant Fusion ProteinsSynechocystisEndopeptidasesHumansInterferon alpha-2EndopeptidasesInterferon alpha-2PhycocyaninRecombinant Fusion ProteinsTEV proteaseDNA and protein fusionhuman rhinovirus 3C proteaseSynechocystis sp. PCC 6803tobacco etch virus protease

Identifiers

PMID41388596
PMCPMC12883899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.